✦ LIBER ✦

Sunitinib plus Erlotinib for the Treatment of Metastatic Non—Small-Cell Lung Cancer: A Novel VEGFR—EGFR Co-Inhibition Treatment Strategy

✍ Scribed by Giorgio V. Scagliotti; George R. Blumenschein Jr; Harry J.M. Groen; Aleksandra Szczesna; János Strausz; Jesús Montesinos; Richard C. Chao; Ramaswamy Govindan

Book ID: 114412080
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 63 KB
Volume: 9
Category: Article
ISSN: 1525-7304
DOI: 10.1016/s1525-7304(11)70866-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NICE guidance on erlotinib for first-lin

NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer

✍ Bernice Dillon; Bhash Naidoo; Helen Knight; Peter Clark 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 44 KB

6511 ORAL Phase II study of erlotinib (E

6511 ORAL Phase II study of erlotinib (E) with or without sunitinib (SU) in the treatment of metastatic non-small cell lung cancer (NSCLC)

✍ Blumenschein, G.R.; Robert, F.; Melnyk, O.; Sutherland, K.C.; Tye, L.; Wang, E.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Egfr Test-Guided Erlotinib Versus Chemot

Egfr Test-Guided Erlotinib Versus Chemotherapy For First-Line Treatment Of Advanced Non-Small Cell Lung Cancer: A Budget Impact Analysis

✍ Bajaj, P.S.; Carlson, J.J.; Goertz, H.P.; Veenstra, D.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

A phase II study of bevacizumab and erlo

A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation

✍ Akerley, Wallace; Boucher, Kenneth; Rich, Nathan; Egbert, Lyle; Harker, Graydon; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Angiogenesis Inhibitors: A Rational Stra

Angiogenesis Inhibitors: A Rational Strategy for Radiosensitization in the Treatment of Non–Small-Cell Lung Cancer?

✍ David Raben; Barb Helfrich 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 340 KB

Is age a negative prognostic factor for

Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?

✍ A.G. Pallis; C. Gridelli 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 182 KB